| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NGM BIOPHARMACEUTICALS INC | General Counsel, Chief Compliance Officer and Secretary | Common Stock | 0 | $0 | $1.34 | 05 Apr 2024 | Direct |
| NGM BIOPHARMACEUTICALS INC | General Counsel, Chief Compliance Officer and Secretary | Restricted Stock Unit | 0 | $0 | $1.34 | 05 Apr 2024 | Direct |
| NGM BIOPHARMACEUTICALS INC | General Counsel, Chief Compliance Officer and Secretary | Stock Option (Right to Buy) | 0 | 05 Apr 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000095017024042625-pierce-valerie-l-2024-03-26 | NGM BIOPHARMACEUTICALS INC | 26 Mar 2024 | 7 | $0 | 4 | General Counsel, Chief Compliance Officer and Secretary | 08 Apr 2024, 16:18 |
| /report/000141588924001542-pierce-valerie-l-2024-01-16 | NGM BIOPHARMACEUTICALS INC | 16 Jan 2024 | 1 | -$6,728 | 4 | SVP, GC & CCO | 18 Jan 2024, 18:02 |
| /report/000120919123054735-pierce-valerie-l-2023-11-06 | NGM BIOPHARMACEUTICALS INC | 06 Nov 2023 | 6 | $0 | 4 | SVP, GC & CCO | 08 Nov 2023, 18:12 |
| /report/000120919123016377-pierce-valerie-l-2023-03-02 | NGM BIOPHARMACEUTICALS INC | 02 Mar 2023 | 3 | $0 | 4 | SVP, GC & CCO | 06 Mar 2023, 16:03 |
| /report/000120919122016200-pierce-valerie-l-2022-03-03 | NGM BIOPHARMACEUTICALS INC | 03 Mar 2022 | 1 | $0 | 4 | SVP, GC & CCO | 04 Mar 2022, 15:08 |